Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABRUPT2
NCT04356859Completed
- Start
- Apr 2021
- Primary completion
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Randomised, open-label trial of albumin (human) in burn injury (2 arms). Primary endpoint: Volume of fluid received during resuscitation for burn injury at 24 hours. Started Apr 2021; status: completed.
02
Drugs
albumin (human)
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT04356859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356859.